Abstract
The high-affinity cell-surface receptor for interleukin-2 (IL-2R) consists of the 75-kilodalton (kd) chain and a 55-kd glycoprotein known as Tac. This report examines the cellular expression of IL-2R and secretion of the soluble form of Tac in immunosuppressed blunt trauma (n = 20, injury severity score -20) and thermally injured (n = 20, Total body surface area greater than 35%) patients. The percentage of IL-2R-expressing peripheral blood mononuclear cells (PBMC) in mitogen-stimulated cultures from patients and age-matched normal donors was determined by direct immunofluorescence with a monoclonal anti-Tac followed by flow cytometry analysis. Levels of soluble Tac in patient sera were measured by a monoclonal antibody-based enzyme-linked immunosorbent assay. Expression of Tac antigen by mitogen-activated PBMC cultures from blunt trauma patients was transiently reduced (by as much as 40%) in 4 of 14 patients examined. Levels of serum Tac were significantly elevated (p less than 0.05) in 15 of 20 blunt trauma patients ranging from 750 to 3000 U/mL compared with 180 to 420 U/mL in control subjects. All burn patients studied 10 to 50 days after the injury demonstrated a significant reduction (by 50% to more than 90%) in the percentage of IL-2 receptor-bearing cells. Similarly serum levels of IL-2R increased significantly (p less than 0.001 to 0.05) in all burn patients studied, reaching concentrations as high as 5500 U/mL. These results suggest that major trauma, whether mechanical or thermal, induces alterations in the T-lymphocyte activation process. However the degree and duration of such changes may vary based on the nature of the injury.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baxter C. R. Fluid volume and electrolyte changes of the early postburn period. Clin Plast Surg. 1974 Oct;1(4):693–703. [PubMed] [Google Scholar]
- Faist E., Mewes A., Baker C. C., Strasser T., Alkan S. S., Rieber P., Heberer G. Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma. J Trauma. 1987 Aug;27(8):837–848. doi: 10.1097/00005373-198708000-00001. [DOI] [PubMed] [Google Scholar]
- Faist E., Mewes A., Strasser T., Walz A., Alkan S., Baker C., Ertel W., Heberer G. Alteration of monocyte function following major injury. Arch Surg. 1988 Mar;123(3):287–292. doi: 10.1001/archsurg.1988.01400270021002. [DOI] [PubMed] [Google Scholar]
- Lawrence E. C., Brousseau K. P., Berger M. B., Kurman C. C., Marcon L., Nelson D. L. Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis. Am Rev Respir Dis. 1988 Apr;137(4):759–764. doi: 10.1164/ajrccm/137.4.759. [DOI] [PubMed] [Google Scholar]
- Leonard W. J., Krönke M., Peffer N. J., Depper J. M., Greene W. C. Interleukin 2 receptor gene expression in normal human T lymphocytes. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6281–6285. doi: 10.1073/pnas.82.18.6281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lowenthal J. W., Greene W. C. Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor. J Exp Med. 1987 Oct 1;166(4):1156–1161. doi: 10.1084/jem.166.4.1156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McIrvine A. J., Mannick J. A. Lymphocyte function in the critically ill surgical patient. Surg Clin North Am. 1983 Apr;63(2):245–261. doi: 10.1016/s0039-6109(16)42980-4. [DOI] [PubMed] [Google Scholar]
- McRitchie D. I., Girotti M. J., Rotstein O. D., Teodorczyk-Injeyan J. A. Impaired antibody production in blunt trauma. Possible role for T cell dysfunction. Arch Surg. 1990 Jan;125(1):91–96. doi: 10.1001/archsurg.1990.01410130097013. [DOI] [PubMed] [Google Scholar]
- Munster A. M. Immunologic response of trauma and burns. An overview. Am J Med. 1984 Mar 30;76(3A):142–145. doi: 10.1016/0002-9343(84)90333-4. [DOI] [PubMed] [Google Scholar]
- Munster A. M. Post-traumatic immunosuppression is due to activation of suppressor T cells. Lancet. 1976 Jun 19;1(7973):1329–1330. doi: 10.1016/s0140-6736(76)92658-1. [DOI] [PubMed] [Google Scholar]
- Nelson D. L., Rubin L. A., Kurman C. C., Fritz M. E., Boutin B. An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro. J Clin Immunol. 1986 Mar;6(2):114–120. doi: 10.1007/BF00918743. [DOI] [PubMed] [Google Scholar]
- Reddy M. M., Grieco M. H. Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations. AIDS Res Hum Retroviruses. 1988 Apr;4(2):115–120. doi: 10.1089/aid.1988.4.115. [DOI] [PubMed] [Google Scholar]
- Reem G. H., Yeh N. H. Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes. Science. 1984 Jul 27;225(4660):429–430. doi: 10.1126/science.6429853. [DOI] [PubMed] [Google Scholar]
- Rubin L. A., Jay G., Nelson D. L. The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol. 1986 Dec 15;137(12):3841–3844. [PubMed] [Google Scholar]
- Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985 Nov;135(5):3172–3177. [PubMed] [Google Scholar]
- Sharon M., Klausner R. D., Cullen B. R., Chizzonite R., Leonard W. J. Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science. 1986 Nov 14;234(4778):859–863. doi: 10.1126/science.3095922. [DOI] [PubMed] [Google Scholar]
- Teodorczyk-Injeyan J. A., Sparkes B. G., Falk R. E., Peters W. J. Polyclonal immunoglobulin production in burned patients--kinetics and correlations with T-cell activity. J Trauma. 1986 Sep;26(9):834–839. doi: 10.1097/00005373-198609000-00010. [DOI] [PubMed] [Google Scholar]
- Teodorczyk-Injeyan J. A., Sparkes B. G., Mills G. B., Falk R. E., Peters W. J. Impaired expression of interleukin-2 receptor (IL2R) in the immunosuppressed burned patient: reversal by exogenous IL2. J Trauma. 1987 Feb;27(2):180–187. doi: 10.1097/00005373-198702000-00015. [DOI] [PubMed] [Google Scholar]
- Teodorczyk-Injeyan J. A., Sparkes B. G., Mills G. B., Falk R. E., Peters W. J. Increase of serum interleukin 2 receptor level in thermally injured patients. Clin Immunol Immunopathol. 1989 May;51(2):205–215. doi: 10.1016/0090-1229(89)90020-2. [DOI] [PubMed] [Google Scholar]
- Teodorczyk-Injeyan J. A., Sparkes B. G., Mills G. B., Peters W. J., Falk R. E. Impairment of T cell activation in burn patients: a possible mechanism of thermal injury-induced immunosuppression. Clin Exp Immunol. 1986 Sep;65(3):570–581. [PMC free article] [PubMed] [Google Scholar]
- Teodorczyk-Injeyan J. A., Sparkes B. G., Peters W. J. Serum interleukin-2 receptor as a possible mediator of immunosuppression after burn injury. J Burn Care Rehabil. 1989 Mar-Apr;10(2):112–118. doi: 10.1097/00004630-198903000-00003. [DOI] [PubMed] [Google Scholar]
- Wagner D. K., Kiwanuka J., Edwards B. K., Rubin L. A., Nelson D. L., Magrath I. T. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. J Clin Oncol. 1987 Aug;5(8):1262–1274. doi: 10.1200/JCO.1987.5.8.1262. [DOI] [PubMed] [Google Scholar]
- Wang B. S., Heacock E. H., Wu A. V., Mannick J. A. Generation of suppressor cells in mice after surgical trauma. J Clin Invest. 1980 Aug;66(2):200–209. doi: 10.1172/JCI109845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wood J. J., Rodrick M. L., O'Mahony J. B., Palder S. B., Saporoschetz I., D'Eon P., Mannick J. A. Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns. Ann Surg. 1984 Sep;200(3):311–320. doi: 10.1097/00000658-198409000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yasuda N., Lai P. K., Ip S. H., Kung P. C., Hinuma Y., Matsuoka M., Hattori T., Takatsuki K., Purtilo D. T. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood. 1988 Apr;71(4):1021–1026. [PubMed] [Google Scholar]
